产品说明书
IDH-305
 |
同义名 : | - |
| CAS号 : | 1628805-46-8 | |
| 货号 : | A943584 | |
| 分子式 : | C23H22F4N6O2 | |
| 纯度 : | 98% | |
| 分子量 : | 490.453 | |
| MDL号 : | MFCD31630851 | |
| 存储条件： |
粉末 Inert atmosphere,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 145 mg/mL(295.64 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Isocitrate dehydrogenase 1 (IDH1) is a NADP+ , metal dependent oxidoreductase and wild-type IDH1 catalyzes the oxidative decarboxylation of isocitrate to give α-ketoglutarate (α-KG), while NADP+ is converted to NADPH. Mutations in IDH1 at Arg132 have been tightly associated to various cancers, including glioma, glioblastoma, AML, chondrosarcoma, and cholangiocarcinoma[2]. IDH-305 is a potent and selective inhibitor of IDH1 R132H and R132C with IC50 of 27 and 28 nM, respectively. HCT116-IDH1R132H+/- mechanistic xenograft model treated with a single oral dose of 200 mg/kg IDH-305 showed reduction of tumor 2-HG concentration with maximal 2-HG inhibition of 87.2 ± 1.5% relative to the vehicle treated tumors 8 h post treatment[2]. | ||
| 作用机制 | IDH-305 demonstrated a hydrophobic collapse conformation. The aminopyrimidine moiety forms a pair of hydrogen bonds with the backbone atoms of Ile128, while the carbonyl of the oxazolidinone forms a hydrogen bond with the backbone amide of Leu120, and the alpha-methyl fits into the methyl nook. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.04mL 0.41mL 0.20mL |
10.19mL 2.04mL 1.02mL |
20.39mL 4.08mL 2.04mL |
| 参考文献 |
|---|